General information about company
Scrip code	539378
Name of the entity	Soni Medicare Ltd
Date of start of financial year	01-04-2016
Date of end of financial year	31-03-2017
Reporting Quarter	Yearly
Date of Report	31-03-2017
Risk management committee	Not Applicable

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory

Textual Information(1)

Is there any change in information of board of directors compare to previous quarter

Yes

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directorsDate of appointment in the current term Date of 
cessationTenure of director (in months)     No of Directorship in listed entities including this listed entity (Refer Regulation 25(1) of Listing Regulations)     Number
 of memberships in Audit/ Stakeholder Committee(s) including this listed
 entity (Refer Regulation 26(1) of Listing Regulations)     No
 of post of Chairperson in Audit/ Stakeholder Committee held in listed 
entities including this listed entity (Refer Regulation 26(1) of Listing
  Regulations)Notes

BIMAL ROY SONI

AFPPS1588H

00716246

Executive Director

Chairperson

20-02-2008

Textual Information(2)

SUMER CHAND JAIN

ACUPJ8426H

00254274

Non-Executive - Independent Director

Not Applicable

20-02-2003

169

Textual Information(3)

Mrs

ANJU SONI

AFPPS1706M

00716193

Non-Executive - Non Independent Director

Not Applicable

02-08-1988

Textual Information(4)

MAHAVIR PRASAD YADAV

AARPY8838K

05249381

Non-Executive - Independent Director

Not Applicable

30-09-2015

Textual Information(5)

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directorsDate of appointment in the current term Date of 
cessationTenure of director (in months)     No of Directorship in listed entities including this listed entity (Refer Regulation 25(1) of Listing Regulations)     Number
 of memberships in Audit/ Stakeholder Committee(s) including this listed
 entity (Refer Regulation 26(1) of Listing Regulations)     No
 of post of Chairperson in Audit/ Stakeholder Committee held in listed 
entities including this listed entity (Refer Regulation 26(1) of Listing
  Regulations)Notes

Mrs

MAMTA SHARMA

AHXPS6519E

07060149

Non-Executive - Independent Director

Not Applicable

30-09-2015

Textual Information(6)

Text Block
Textual Information(1)	Mr. BIMAL ROY SONI is Executive Director, MD cum Chairperson. Mrs. ANJU SONI is Non Executive cum Non Independent Director. Mr. SUMER CHAND JAIN is Independent Director. Mr. MAHAVIR PRASAD YADAV is Independent Director. Mrs. MAMTA SHARMA is Independent Director. Ms. AAKANSHA KHANDELWAL is Company Secretary. Ms. SONAM CHANDAK is Chief Financial Officer
Textual Information(2)	Mr. Bimal Roy Soni originally appointed as director on dated 02-08-1988 and redesignated as Managing Director on dated 20-02-2008
Textual Information(3)	Mr. SUMER CHAND JAIN is Chairman of Nomination and Remuneration committee and Member of Stakeholder Committee
Textual Information(4)	Mrs. ANJU SONI is member of the Audit Committee and Nomination and Remuneration Committee and Chairperson of Stakeholders Committee
Textual Information(5)	Mr. MAHAVIR PRASAD YADAV is Chairperson of Audit Committee and Member of Nomination and Remuneration committee and Stakeholder Committee.
Textual Information(6)	Mrs. MAMTA SHARMA is member of Audit Committee, Nomination and Remuneration committee and Stakeholder Committee

Annexure 1
II. Composition of Committees
Disclosure of notes on composition of committees explanatory
Is there any change in information of committees compare to previous quarter				No

Annexure 1
Annexure 1
III. Meeting of Board of Directors
Disclosure of notes on meeting of board of directors explanatory			Textual Information(1)
Sr	Date(s) of meeting (if any) in the previous quarter	Date(s) of meeting (if any) in the current quarter	Maximum gap between any two consecutive (in number of days)
1	02-12-2016
2		01-02-2017	60
3		08-02-2017	6

Text Block
Textual Information(1)	02-12-2016 Approve the resignation of Pooja Sharma from the post of Company Secretary and Appointment of Aakansha Khandelwal as the Company Secretary. 01-02-2017 Approval for sanctioning of unsecured Loan From Bank. 08-02-2017 Approve the Unaudited financial results for the quarter ended 31st December, 2016, take note of Corporate Governance Report and take note of the Shareholding Pattern.

Annexure 1
IV. Meeting of Committees
Disclosure of notes on meeting of committees explanatory						Textual Information(1)
Sr	Name of Committee	Date(s) of meeting of the committee in the relevant quarter	Whether requirement of Quorum met (Yes/No)	Requirement of Quorum met (details)	Date(s) of meeting of the committee in the previous quarter	Maximum gap between any two consecutive meetings (in number of days)	Name of other committee
1	Audit Committee	08-02-2017	Yes	All the members participated in meeting	11-11-2016	88

Text Block
Textual Information(1)	A) Stakeholder Grievance Committee No Meeting was held during the quarter B) Nomination and Remuneration Committee No Meeting was held during the quarter. C) Audit Committee 08-02-2017 To consider and approve the Unaudited Quarterly Financial Results along with the limited review report of the Auditor for the Quarter ended on 31st December, 2016.

Annexure 1
V. Related Party Transactions
Sr	Subject	Compliance status (Yes/No/NA)	If status is “No” details of non-compliance may be given here.
1	Whether prior approval of audit committee obtained	Yes
2	Whether shareholder approval obtained for material RPT	NA
3	Whether details of RPT entered into pursuant to omnibus approval have been reviewed by Audit Committee	NA
Disclosure of notes on related party transactions			Textual Information(1)
Disclosure of notes of material transaction with related party			Textual Information(2)

Text Block

Textual Information(1)

SONI MEDICARE LIMITED

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JAN. 17 TO MARCH 17

S.NO.

NAME OF PERSON / PARTY

RELATION

TRASACTION

AMOUNT

1

DR. BIMAL ROY SONI

MANAGING DIRECTOR

REMUNERATION

                   300,000.00

LEASE RENT - BUILDING

                   180,000.00

2

DR. ANJU SONI

CONSULTANCY

                   313,000.00

3

MR. NAMIT SONI

SON OF DIRECTOR

SALARY

                   300,000.00

4

MRS. NEHA SONI

DAUGHTER IN LAW OF DIRECTOR

SALARY

                   150,000.00

5

M/S S S PHARMACY

PARTNERSHIP FIRM IN WHICH DIRECTORS ARE PARTNER

MEDICINE AND MEDICAL CONSUMABLES PURCHASED

                      65,118.00

Textual Information(2)

SONI MEDICARE LIMITED

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JAN. 17 TO MARCH 17

Annexure 1
VI. Affirmations
Sr	Subject	Compliance status (Yes/No)
1	The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015	Yes
2	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit Committee	Yes
3	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committee	Yes
4	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committee	Yes
5	The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 100 listed entities)	NA
6	The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.	Yes
7	The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.	Yes
8	This report and/or the report submitted in the previous quarter has been placed before Board of Directors.	Yes
9	Any comments/observations/advice of Board of Directors may be mentioned here:	Textual Information(1)

Text Block
Textual Information(1)	No comments/observations/advice of Board of Directors been noted

Annexure II
Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of Listing Regulations
Sr	Item	Compliance status (Yes/No/NA)	If status is “No” details of non-compliance may be given here.	Web address
1	Details of business	Yes		http://www.sonihospitals.com/AboutMediCare.aspx
2	Terms and conditions of appointment of independent directors	Yes		http://www.sonihospitals.com/Management.aspx
3	Composition of various committees of board of directors	Yes		http://www.sonihospitals.com/Management.aspx
4	Code of conduct of board of directors and senior management personnel	Yes		http://www.sonihospitals.com/CodeOfCndct.aspx
5	Details of establishment of vigil mechanism/ Whistle Blower policy	Yes		http://www.sonihospitals.com/
6	Criteria of making payments to non-executive directors	Yes		http://www.sonihospitals.com/AnnualRprt.aspx?rpt=anl
7	Policy on dealing with related party transactions	Yes		http://www.sonihospitals.com/AnnualRprt.aspx?rpt=anl
8	Policy for determining ‘material’ subsidiaries	NA
9	Details of familiarization programmes imparted to independent directors	NA

Annexure II
Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)
I. Disclosure on website in terms of Listing Regulations
Sr	Item	Compliance status (Yes/No/NA)	If status is “No” details of non-compliance may be given here.	Web address
10	Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances	Yes		http://www.sonihospitals.com/CorpoInfo.aspx
11	email address for grievance redressal and other relevant details	Yes		http://www.sonihospitals.com/CorpoInfo.aspx
12	Financial results	Yes		http://www.sonihospitals.com/QuartInfo.aspx
13	Shareholding pattern	Yes		http://www.sonihospitals.com/SharePtrn.aspx
14	Details of agreements entered into with the media companies and/or their associates	Yes		http://www.sonihospitals.com/
15	New name and the old name of the listed entity	NA
Disclosure of notes on website in terms of Listing Regulations explantory [Text Block]				Textual Information(1)

Text Block
Textual Information(1)	DISCLOSURE OF NOTES ON WEBSITE IN TERMS OF LISTING REGULATIONS EXPLANATORY IS ELABORATED ON THE WEB ADDRESS http://www.sonihospitals.com/InfoMemorandum.aspx

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is “No” details of non-compliance may be given here.
1	Independent director(s) have been appointed in terms of specified criteria of ‘independence’ and/or ‘eligibility’	16(1)(b) & 25(6)	Yes
2	Board composition	17(1)	Yes
3	Meeting of Board of directors	17(2)	Yes
4	Review of Compliance Reports	17(3)	Yes
5	Plans for orderly succession for appointments	17(4)	Yes
6	Code of Conduct	17(5)	Yes
7	Fees/compensation	17(6)	Yes
8	Minimum Information	17(7)	Yes
9	Compliance Certificate	17(8)	Yes
10	Risk Assessment & Management	17(9)	Yes

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is “No” details of non-compliance may be given here.
11	Performance Evaluation of Independent Directors	17(10)	Yes
12	Composition of Audit Committee	18(1)	Yes
13	Meeting of Audit Committee	18(2)	Yes
14	Composition of nomination & remuneration committee	19(1) & (2)	Yes
15	Composition of Stakeholder Relationship Committee	20(1) & (2)	Yes
16	Composition and role of risk management committee	21(1),(2),(3),(4)	NA
17	Vigil Mechanism	22	Yes
18	Policy for related party Transaction	23(1),(5),(6),(7) & (8)	Yes
19	Prior or Omnibus approval of Audit Committee for all related party transactions	23(2), (3)	NA
20	Approval for material related party transactions	23(4)	Yes

Annexure II
II. Annual Affirmations
Sr	Particulars	Regulation Number	Compliance status (Yes/No/NA)	If status is “No” details of non-compliance may be given here.
21	Composition of Board of Directors of unlisted material Subsidiary	24(1)	NA
22	Other Corporate Governance requirements with respect to subsidiary of listed entity	24(2),(3),(4),(5) & (6)	NA
23	Maximum Directorship & Tenure	25(1) & (2)	Yes
24	Meeting of independent directors	25(3) & (4)	Yes
25	Familiarization of independent directors	25(7)	NA
26	Memberships in Committees	26(1)	Yes
27	Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel	26(3)	Yes
28	Disclosure of Shareholding by Non-Executive Directors	26(4)	Yes
29	Policy with respect to Obligations of directors and senior management	26(2) & 26(5)	Yes
	Any other information to be provided		Textual Information(1)

Text Block

Textual Information(1)

SONI MEDICARE LIMITED

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JAN. 17 TO MARCH 17

S.NO.	NAME OF PERSON / PARTY	RELATION	TRASACTION	AMOUNT
1	DR. BIMAL ROY SONI	MANAGING DIRECTOR	REMUNERATION	300,000.00
			LEASE RENT - BUILDING	180,000.00

2	DR. ANJU SONI	CONSULTANCY		313,000.00

3	MR. NAMIT SONI	SON OF DIRECTOR	SALARY	300,000.00

4	MRS. NEHA SONI	DAUGHTER IN LAW OF DIRECTOR	SALARY	150,000.00

5	M/S S S PHARMACY	PARTNERSHIP FIRM IN WHICH DIRECTORS ARE PARTNER	MEDICINE AND MEDICAL CONSUMABLES PURCHASED	65,118.00

Annexure II
III. Affirmations
Sr	Particulars	Compliance status (Yes/No/NA)
1	The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been complied	NA
	Any other information to be provided	Textual Information(1)

Text Block
Textual Information(1)	NA

Signatory Details
Name of signatory	BIMAL ROY SONI
Designation of person	Managing Director
Place	JAIPUR
Date	11-04-2017

General information about company

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Text Block

Annexure 1

II. Composition of Committees

Annexure 1

Annexure 1

III. Meeting of Board of Directors

Text Block

Annexure 1

IV. Meeting of Committees

Text Block

Annexure 1

V. Related Party Transactions

Text Block

Annexure 1

VI. Affirmations

Text Block

Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

Text Block

Annexure II

II. Annual Affirmations

Annexure II

II. Annual Affirmations

Annexure II

II. Annual Affirmations

Text Block

Annexure II

III. Affirmations

Text Block

Signatory Details